SCHEMBL7683433

SCHEMBL7683433

CCCCCc1c(Cl)n(CCc2ccccc2)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cn1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 10/20 0.40
AGTR2 P50052 8/20 0.40
CNOT7 Q9UIV1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679819 0.98 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9130896 0.94 AGTR1 (0.38) AGTR1AGTR2
SCHEMBL7686318 0.94 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL7676847 0.94 AGTR1 (0.37) AGTR1AGTR2
SCHEMBL7679481 0.94 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL7686551 0.94 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL7679359 0.92 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL7676696 0.92 AGTR1 (0.39) AGTR1AGTR2
SCHEMBL7682430 0.91 AGTR1 (0.38) AGTR1AGTR2CNOT7
SCHEMBL7686297 0.91 AGTR1 (0.38) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492397-B1 SUCH AS 1-PROPYL-4-BUTYL-1,3-DIHYDRO-3-((5-(2-(1H-TETRAZOL-5-YL)PHENYL)-2 -PYRIDINYL)METHYL)-2H-IMIDAZOL-2-ONE; ANGIO-TENSIN II ANTAGONISTS; CIRCULATORY DISORDERS; HYPERTENSION, CONGESTIVE HEART FAILURE PHARMACIA CORPORATION 2002-12-10 US disclosed
US-5441970-A Administering angiotensin II antagonists to treat congestive heart failure or hypertension G. D. SEARLE & CO. (US) 1995-08-15 US disclosed
EP-0579766-A1 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1994-01-26 EP disclosed
US-5164403-A Hypotensive agents, cardiovascular disorders G. D. SEARLE & CO. (US) 1992-11-17 US disclosed
WO-1992017469-A2 N-ARYLHETEROARYLALKYL IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-10-15 WO disclosed
EP-0508393-A1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders G.D. Searle & Co. (US) 1992-10-14 EP disclosed